amphetamine has been researched along with Mood Disorders in 8 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A potentiating mechanism in drug use disorders appears to be synaptic plasticity, which is regulated by dopamine transmission." | 1.37 | Effects of dopamine and glutamate on synaptic plasticity: a computational modeling approach for drug abuse as comorbidity in mood disorders. ( Kikuchi, S; Qi, Z; Tretter, F; Voit, EO, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Der-Avakian, A | 1 |
| D'Souza, MS | 1 |
| Pizzagalli, DA | 1 |
| Markou, A | 1 |
| Furlotti, G | 1 |
| Alisi, MA | 1 |
| Cazzolla, N | 1 |
| Dragone, P | 1 |
| Durando, L | 1 |
| Magarò, G | 1 |
| Mancini, F | 1 |
| Mangano, G | 1 |
| Ombrato, R | 1 |
| Vitiello, M | 1 |
| Armirotti, A | 1 |
| Capurro, V | 1 |
| Lanfranco, M | 1 |
| Ottonello, G | 1 |
| Summa, M | 1 |
| Reggiani, A | 1 |
| Pan, JQ | 1 |
| Lewis, MC | 1 |
| Ketterman, JK | 1 |
| Clore, EL | 1 |
| Riley, M | 1 |
| Richards, KR | 1 |
| Berry-Scott, E | 1 |
| Liu, X | 1 |
| Wagner, FF | 1 |
| Holson, EB | 1 |
| Neve, RL | 1 |
| Biechele, TL | 1 |
| Moon, RT | 1 |
| Scolnick, EM | 1 |
| Petryshen, TL | 1 |
| Haggarty, SJ | 1 |
| Marcus, SC | 1 |
| Durkin, M | 1 |
| Qi, Z | 1 |
| Kikuchi, S | 1 |
| Tretter, F | 1 |
| Voit, EO | 1 |
| Latapy, C | 1 |
| Rioux, V | 1 |
| Guitton, MJ | 1 |
| Beaulieu, JM | 1 |
| Weiss, JM | 1 |
| West, CH | 1 |
| Emery, MS | 1 |
| Bonsall, RW | 1 |
| Moore, JP | 1 |
| Boss-Williams, KA | 1 |
| Siever, L | 1 |
| Insel, T | 1 |
| Uhde, T | 1 |
2 reviews available for amphetamine and Mood Disorders
| Article | Year |
|---|---|
Rats selectively-bred for behavior related to affective disorders: proclivity for intake of alcohol and drugs of abuse, and measures of brain monoamines.
Topics: Alcohol Drinking; Amphetamine; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Breeding; Cocai | 2008 |
Noradrenergic challenges in the affective disorders.
Topics: Amphetamine; Behavior; Clonidine; Growth Hormone; Humans; Hydrocortisone; Mood Disorders; Neurons; N | 1981 |
6 other studies available for amphetamine and Mood Disorders
| Article | Year |
|---|---|
Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research.
Topics: Amphetamine; Animals; Benzothiazoles; Conditioning, Operant; Discrimination Learning; Disease Models | 2013 |
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
Topics: Adenosine Triphosphate; Amphetamine; Animals; Binding, Competitive; Central Nervous System Stimulant | 2015 |
AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.
Topics: Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Cell Line, Transformed; Corpus Striatu | 2011 |
Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Topics: Achievement; Adolescent; Amphetamine; Anxiety Disorders; Attention Deficit and Disruptive Behavior D | 2011 |
Effects of dopamine and glutamate on synaptic plasticity: a computational modeling approach for drug abuse as comorbidity in mood disorders.
Topics: Amphetamine; Comorbidity; Computer Simulation; Dopamine; Dopamine Uptake Inhibitors; GABAergic Neuro | 2011 |
Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Enzyme Activation; Female; Gene Deletion; Gene S | 2012 |